DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
LUM001 is an investigational drug.
There have been 14 clinical trials for LUM001. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2019.
The most common disease conditions in clinical trials are Cholestasis, Alagille Syndrome, and Syndrome. The leading clinical trial sponsors are Shire, Mirum Pharmaceuticals, Inc., and Lumena Pharmaceuticals, Inc.
There are eight US patents protecting this investigational drug and one hundred and twenty-four international patents.
Recent Clinical Trials for LUM001
|A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).||Mirum Pharmaceuticals, Inc.||Phase 2|
|Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai||Mirum Pharmaceuticals, Inc.||Phase 2|
|MRX-800: A Long-Term Safety Study of Maralixibat in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study||Mirum Pharmaceuticals, Inc.||Phase 2|
Top disease conditions for LUM001
Top clinical trial sponsors for LUM001
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|LUM001||Start Trial||Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake||G.D. Searle and Company (Skokie, IL)||Start Trial|
|LUM001||Start Trial||Substituted 5-aryl-benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake||G.D. Searle and Company (Skokie, IL)||Start Trial|
|LUM001||Start Trial||Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake||G.D. Searle and Company (Skokie, IL)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|